ALK1 gene rearrangement

Intended Use: ALK1 gene rearrangement

Anaplastic lymphoma kinase-positive large B-cell Lymphoma (ALK+LBCL) is a diffuse, monomorphic neoplasm of large B cells with a plasmablastic immunophenotype and ALK Expression due to ALK rearrangement.

Specimen Required

Paraffin-embed tissue (3–4-micron thick sections in positively charged/silanized slides).

Patient Preparation
  • Sample collection : Tumor tissue (FFPE tissue block). Submit block/slides along with the corresponding Histopathology Report.
  • Specimen preparation: Formalin fix (10 percent neutral buffered formalin) and paraffin-embed tissue (3-4 micron thick sections). Fixative duration: 6-48 hours.
  • Storage/Transport Temperature: Room temperature. Protect paraffin block from excessive heat. Also acceptable: Refrigerated. Ship in cooled container during summer months.
  • Unacceptable Conditions: Paraffin block with no tumor tissue remaining. Specimens fixed in any fixative other than 10 percent neutral buffered formalin. Decalcified specimens. Specimens with fixation delayed for more than one hour. Tissue fixed or less than 6 hours of greater than 48 hours.
  • Remarks
  • Stability: Ambient: Indefinitely; Refrigerated: Indefinitely; Frozen: Unacceptable
Methodology

Fluorescence in situ Hybridization (FISH)

Sample received to report Turnaround time (TAT)

5 working days

Reference Interval

————-

Interpretive Data

The most recent WHO classification of Tumours of Hematopoietic and Lymphoid Tissues (Revised 5th edition) is used for interpretation criteria for evaluating ALK1 gene rearrangement status.

Resources

Sample Reports